NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/04/2025
Back to search
Official data from USPTO
GALT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/05/2025
Trademark type
Combined
Nice classes
5, 35
Filing date
06/23/2017
Registration date
10/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/04/2025
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
12/07/2016
First use in commerce
12/07/2016
Drawing code
3
Owner type
16
Owner location
Atlanta, GA
Examiner
MARTIN, LIEF
Current location
Historical data usage
Mark description
The mark consists of the wording "GALT PHARMACEUTICALS" with horizontal lines appearing above and below the word "PHARMACEUTICALS". "GALT" appears in blue and black above the word "PHARMACEUTICALS". The remainder of the mark is black.
Holders and representatives
Holders
Galt Pharmaceuticals, LLC
Representatives
Chelsea G. Swanson
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
line of medicated and pharmaceutical preparationsboth prescription and over-the-counterfor use in connection with humanspharmaceutical preparations for treating insomnia and sleep disordersclinical depressionsymptoms of Osteoarthritis and Rheumatoid Arthritisacute painmusculoskeletal disordersinfectionsskin irritationsdiabetesvestibular disordersgastrointestinal disordersinflammationmental health disorders
Class 35
Wholesale store services featuring pharmaceuticals; distributorships in the field of prescription drug and pharmaceutical products
Publications
History of USPTO decisions and trademark events.
35 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/04/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/23/2025
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
04/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/14/2025
ES8R
TEAS SECTION 8 RECEIVED
10/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/23/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/23/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/19/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
09/12/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
09/11/2018
IUAA
USE AMENDMENT ACCEPTED
09/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/11/2018
IUAF
USE AMENDMENT FILED
09/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/06/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/14/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/17/2018
GNFR
FINAL REFUSAL E-MAILED
03/17/2018
CNFR
FINAL REFUSAL WRITTEN
03/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2018
ALIE
ASSIGNED TO LIE
02/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/14/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2017
GNRT
NON-FINAL ACTION E-MAILED
09/15/2017
CNRT
NON-FINAL ACTION WRITTEN
09/15/2017
DOCK
ASSIGNED TO EXAMINER
09/14/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/30/2017
NWAP
NEW APPLICATION ENTERED
06/27/2017
Continuous trademark protection
Get notified about every new filing that threatens GALT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.